Standard BioTools Inc

LAB
2,33
-0,08 (-3,32%)
Pre Mercato
Ultimo aggiornamento: 10:06:25
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:31EDGAR2Form 8-K - Current report
08/5/202422:01GLOBEStandard BioTools Reports First Quarter 2024 Financial..
25/4/202414:01GLOBEStandard BioTools Announces Operational Restructuring Plan..
25/4/202414:00GLOBEStandard BioTools Announces Conference Call and Webcast for..
08/4/202414:00GLOBEStandard BioTools Introduces New High-Throughput Multiplexed..
03/4/202422:01GLOBEStandard BioTools Announces Multi-Year Strategic Engagement..
18/3/202413:12GLOBEStandard BioTools Announces Exchange of All Outstanding..
07/3/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:05EDGAR2Form 8-K - Current report
28/2/202422:01GLOBEStandard BioTools Reports Fourth Quarter and Full Year 2023..
26/2/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/2/202414:00GLOBEStandard BioTools and Next Gen Diagnostics Announce..
22/2/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:05GLOBEStandard BioTools to Participate in Upcoming Investor..
14/2/202421:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:30GLOBEStandard BioTools Announces Conference Call and Webcast for..
08/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/2/202414:30GLOBEStandard BioTools and Navignostics Announce Collaboration..
02/2/202422:49EDGAR2Form S-3/A - Registration statement under Securities Act of..
19/1/202423:07EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202423:05EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202423:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202422:33EDGAR2Form 8-K/A - Current report: [Amend]
12/1/202420:04EDGAR2Form SC 13D/A - General statement of acquisition of..
10/1/202402:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202400:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202400:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202423:13EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202423:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202414:39EDGAR2Form 8-K - Current report
08/1/202414:30GLOBEStandard BioTools Announces Preliminary Fourth Quarter and..
05/1/202414:53EDGAR2Form 8-K - Current report
05/1/202414:46GLOBEStandard BioTools Completes Merger with SomaLogic, Creating..
05/1/202404:23GLOBEStandard BioTools Stockholders Approve Merger with SomaLogic
05/1/202403:44PRNUSSomaLogic Stockholders Vote to Approve Standard BioTools..
29/12/202323:26EDGAR2Form 425 - Prospectuses and communications, business..
29/12/202323:25EDGAR2Form 8-K - Current report
29/12/202323:04GLOBEGlass Lewis Recommends Standard BioTools Stockholders Vote..
28/12/202322:16PRNUSDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to..
26/12/202321:59PRNUSSomaLogic Issues Statement Correcting Madryn Asset..
23/12/202300:57GLOBEISS Recommends Standard BioTools Stockholders Vote “FOR” All..
21/12/202314:00GLOBESomaLogic Issues Letter to Stockholders Reiterating..
20/12/202315:00GLOBESkye Fund III Issues Letter Regarding Opposition to..
Apertura: Min: Max:
Chiusura: 2,41

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network